Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD46 in meningococcal disease.

Linda Johansson1, Anne Rytkonen, Peter Bergman

  • 1Microbiology and Tumor Biology Center, Nobels väg 16, Box 280, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Science (New York, N.Y.)
|July 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.

Molecular therapy. Advances·2026
Same author

Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.

The Lancet. Microbe·2026
Same author

Persistent spread of carbapenemase-producing Klebsiella pneumoniae in acute care hospitals in 36 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.

The Lancet. Microbe·2026
Same author

Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity.

EBioMedicine·2026
Same author

Autoantibodies to Joint-Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Limosilactobacillus reuteri metabolites modulate immune pathways and intestinal barrier repair after 5 fluorouracil exposure.

Scientific reports·2026
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
See all related articles

A new mouse model using human CD46 allows researchers to study how Neisseria meningitidis causes sepsis and meningitis. This model helps understand bacterial interactions with human cells for potential vaccine development.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • Neisseria meningitidis is a human pathogen causing sepsis and meningitis.
  • Bacterial pili mediate interactions with host cell proteins like CD46.
  • CD46 regulates complement activation, a key immune response.

Purpose of the Study:

  • To investigate the role of human CD46 in Neisseria meningitidis pathogenesis.
  • To develop a relevant animal model for studying meningococcal disease.
  • To explore CD46-mediated bacterial entry into the central nervous system.

Main Methods:

  • Generation of transgenic mice expressing human CD46.
  • Intranasal and intraperitoneal challenge of mice with piliated and non-piliated N. meningitidis.
  • Assessment of bacterial translocation across the blood-brain barrier.

Related Experiment Videos

Main Results:

  • Transgenic mice expressing human CD46 were susceptible to meningococcal disease.
  • Piliated bacteria efficiently caused disease after intranasal challenge, indicating mucosal interaction.
  • Bacteria crossed the blood-brain barrier in CD46 transgenic mice.

Conclusions:

  • Human CD46 facilitates pilus-dependent interactions at the epithelial mucosa.
  • The human CD46 transgenic mouse model is valuable for studying N. meningitidis pathogenesis.
  • This model can aid in developing vaccines against meningococcal disease.